Howard G. Welgus, Director at Arcutis Biotherapeutics, Inc. (ARQT), sold 20,000 shares at $25.05 ($501K) on 2026-02-02, disclosed to the SEC on 2026-02-04.
Open-market sale of $501k ARQT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.05 | 10,000 | $250K | 50.0% |
| 2 | $25.05 | 10,000 | $251K | 50.0% |
| Total | $25.05 avg | 20,000 | $501K | 100% |
| Filing → |
| ARQT | SELL | 2026-07-17 | $127K | — | Filing → |
| ARQT | SELL | 2026-06-17 | $116K | — | Filing → |
| ARQT | SELL | 2026-05-05 | $164K | — | Filing → |